Heart Closure Devices Market Size

The global heart closure devices market was valued at USD 4 billion in 2024 and is expected to exhibit growth at a CAGR of 15.9% from 2025 to 2034. High market growth can be attributed to the growing prevalence of cardiovascular diseases, rising preference for minimally invasive procedures, and favorable reimbursement policies, among other contributing factors.

Cardiovascular diseases (CVDs) continue to be a primary global health concern, claiming millions of lives annually. According to the World Health Organization (WHO), CVDs account for approximately 17.9 million deaths each year. Contributing to this alarming trend are an aging population, a surge in lifestyle-related risk factors such as obesity, hypertension, and diabetes, and increasingly sedentary lifestyles. As a result, there is a heightened demand for minimally invasive solutions, such as heart closure devices, which effectively address structural heart defects across diverse patient demographics.

Additionally, heart closure devices are highly sought after due to their minimally invasive nature, offering patients an alternative to traditional open-heart surgery. These devices are typically implanted via catheter-based procedures, leading to shorter recovery times, less pain, and reduced hospital stays compared to surgical interventions. As minimally invasive procedures gain popularity among both healthcare providers and patients, the demand for heart closure devices continues to expand, supporting significant growth in the market.

Heart closure devices are medical devices used to close abnormal openings in the heart, particularly atrial or ventricular septal defects. These defects are congenital conditions where abnormal openings exist between the chambers of the heart, allowing blood to flow in unintended directions.